Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.

Jiang Y, Iakova P, Jin J, Sullivan E, Sharin V, Hong IH, Anakk S, Mayor A, Darlington G, Finegold M, Moore D, Timchenko NA. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology. 2013 Mar; 57(3):1098-106.

View in: PubMed

subject areas

Animals
Base Sequence
Carcinoma, Hepatocellular
CCAAT-Enhancer-Binding Protein-alpha
CCAAT-Enhancer-Binding Protein-beta
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Histone Deacetylase 1
Humans
Liver Neoplasms
Mice
Mice, Inbred Strains
Mice, Knockout
Molecular Sequence Data
Promoter Regions, Genetic
Proteasome Endopeptidase Complex
Proto-Oncogene Proteins
Receptors, Cytoplasmic and Nuclear
RNA, Small Interfering
Transcription Factors

authors with profiles

Angel Mauricio Mayor

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support